Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V37040 | (D-Arg1,D-Pro2,D-Trp7·9,Leu11)-Substance P | 84676-91-5 | (D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P is an antagonist of the neuropeptide Substance P. | |
V37041 | (D-Arg1,D-Trp5·7·9,Leu11)-Substance P | (D-Arg1,D-Trp5·7·9,Leu11)-Substance P is a peptide compound. | ||
V36700 | (D-Arg2)-Dermorphin (1-4) amide | (D-Arg2)-Dermorphin (1-4) amide is a peptide compound. | ||
V36701 | (D-Arg2,Lys4)-Dermorphin (1-4) amide | 118476-85-0 | DALDA is a potent and selective μ-opioid receptor agonist (activator) with Ki of 1.69 nM. | |
V36699 | (D-Arg2,Sar4)-Dermorphin (1-4) | 90549-86-3 | (D-Arg2,Sar4)-Dermorphin (1-4) is a peptide compound. | |
V36716 | (D-Arg6)-Dynorphin A (1-13)|[D-Arg6]-Dynorphin A (1-13),porcine | 75921-87-8 | (D-Arg6)-Dynorphin A (1-13)|[D-Arg6]-Dynorphin A (1-13),porcine is a peptide compound. | |
V36563 | (D-Arg6,Asn10)-MCH (6-16) amide (human, mouse, rat) | (D-Arg6,Asn10)-MCH (6-16) amide (human, mouse, rat) is a peptide compound. | ||
V36717 | (D-Arg8)-Dynorphin A (1-13) | 125357-12-2 | (D-Arg8)-Dynorphin A (1-13) is a peptide compound. | |
V36564 | (D-Bpa13,Tyr19)-MCH (human, mouse, rat) | 183606-10-2 | (D-Bpa13,Tyr19)-MCH (human, mouse, rat) is a peptide compound. | |
V37031 | (D-Glu5,D-Trp7·9·10)-Substance P (5-11) | 289632-61-7 | (D-Glu5,D-Trp7·9·10)-Substance P (5-11) is a peptide compound. | |
V36569 | (D-Leu2)-Melanocyte-Stimulating Hormone-Release Inhibiting Factor | 39705-60-7 | (D-Leu2)-Melanocyte-Stimulating Hormone-Release Inhibiting Factor is a peptide compound. | |
V34918 | (D-Phe12)-Bombesin | 108437-87-2 | (D-Phe12)-Bombesin is a peptide compound. | |
V36686 | (D-Phe12,Nle21·38)-CRF (12-41) (human, rat) | 129133-27-3 | (D-Phe12,Nle21·38)-CRF (12-41) (human, rat) is a peptide compound. | |
V36687 | (D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat) | (D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat) is a peptide compound. | ||
V37074 | (D-Phe2)-VIP (human, bovine, porcine, rat) | 104051-15-2 | (D-Phe2)-VIP (human, bovine, porcine, rat) is a peptide compound. | |
V36552 | (D-Phe2·6,Pro3)-LHRH | 67019-15-2 | (D-Phe2·6,Pro3)-LHRH is a peptide compound. | |
V37015 | (D-Phe5,Cys6·11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide | 340821-13-8 | (D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide (Compound 4) is a somatostatin analog that can inhibit SSTR5, SSTR3, SSTR2, SSTR1 and SSTR4 The Kd are 0.61, 11.05, 23.5, 1200 and >1000 nM respectively. | |
V34922 | (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) | 124199-90-2 | (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin(6-14) is a bombesin antagonist and may be utilized in cancer-related research. | |
V37004 | (D-Phe7)-Somatostatin-14 | 64813-74-7 | (D-Phe7)-Somatostatin-14 is a bioactive peptide discovered by peptide screening. | |
V36842 | (D-Pro12)-α-MSH (11-13) (free acid) | (D-Pro12)-α-MSH (11-13) (free acid) is a peptide compound. |